BFLY vs LNTH vs CV Stock Comparison

Butterfly Network, Lantheus Holdings and CapsoVision Prices as of Oct 27, 2026 Peers: Industry group
1 more company in this comparison (CBLL) Create a free account to keep reading and compare up to 10 companies.
BFLY Butterfly Network, Inc.
$7.40 -21.2% 1M +236.4% 1Y
Market cap
$2.02B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins
LNTH Lantheus Holdings, Inc.
$100.15 +0.4% 1M +72.3% 1Y
Market cap
$6.52B
P/E
23.7x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
5 wins
CV CapsoVision, Inc
$6.75 +1.5% 1M +38.9% 1Y
Market cap
$348.56M
P/E
–
Revenue (TTM)
$14.41M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

7 decided of 12

Lantheus Holdings leads on 5 of the 12 questions below (Lantheus Holdings 5, Butterfly Network 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYLNTHCVLeader
Larger companyMarket capitalisation $2.02B $6.52B $348.56M LNTH
Cheaper on earningsLower P/E, profitable companies only -27.0x 23.7x -12.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.4x — –
Faster revenue growthRevenue growth, trailing twelve months +28.1% +2.3% +14.6% BFLY
More profitableNet margin, trailing twelve months -66.7% 17.7% -190.2% LNTH
Better return on capitalReturn on invested capital — 12.5% — –
Less leveragedLower net debt / EBITDA — -0.1x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +236.4% +72.3% +38.9% BFLY
Better 5-year returnAnnualised price return, 5 years -6.3%/yr +34.4%/yr — LNTH
Less volatileAnnualised volatility, 1 year 114.8% 32.3% 96.0% LNTH
Higher overall scoreMean of the five percentile scores vs peers 45/100 80/100 37/100 LNTH

Percentile Scorecard

BFLYLNTHCV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYLNTHCV
Valuation 28 #164 of 227 80 #46 of 227 5 #216 of 227
Growth 68 #71 of 219 63 #82 of 219 44 #123 of 219
Profitability 32 #140 of 206 94 #13 of 206 23 #159 of 206
Financial Health 61 #94 of 238 69 #74 of 238 76 #58 of 238
Shareholder Returns 37 #85 of 134 93 #11 of 134 –
Overall 45 80 37
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • LNTH ranked among 247 companies in Medical Devices and Diagnostics
  • CV ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYLNTHCVSPY
1 month -21.2%+0.4%+1.5% -0.2%
3 months +3.1%-2.4%+2.0% +3.9%
6 months +43.4%+19.9%-0.4% +8.2%
Year to date +94.7%+50.5%-36.9% +12.9%
1 year +236.4%+72.3%+38.9% +12.3%
3 years +836.7%+49.9%— +87.4%
3 years, per year +110.9%+14.4%— +23.3%
5 years -27.6%+337.5%— +67.9%
5 years, per year -6.3%+34.4%— +10.9%
10 years —+1,092.3%— +261.1%
10 years, per year —+28.1%— +13.7%

Risk

MeasureBFLYLNTHCVSPY
Volatility, 1Y 114.8%32.3%96.0% 12.7%
Downside volatility, 1Y 91.7%27.5%89.4% 12.7%
Beta vs S&P 500, 1Y 3.000.590.61 1.00
Return / volatility, 1Y 2.062.240.41 0.97
Max drawdown, 5Y -93.4%-59.5%-67.8% -25.4%
From 52-week high -25.6%-9.7%-53.2% -1.2%
52-week high $9.94$110.94$14.42 $779.14
52-week low $1.97$50.69$4.59 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYLNTHCV
P/E now vs peer median -25.9xmedian 29.6x 23.7xmedian 29.6x -12.3xmedian 29.6x
P/S now vs peer median 15.7xmedian 2.9x 4.2xmedian 2.9x 23.4xmedian 2.9x
EV/EBITDA now vs peer median -22.6xmedian 17.4x 16.5xmedian 17.4x -12.3xmedian 17.4x
P/FCF now vs peer median -62.8xmedian 22.3x 16.9xmedian 22.3x —median 22.3x
P/B now vs peer median 9.3xmedian 2.3x 5.0xmedian 2.3x 25.7xmedian 2.3x
PEG now vs peer median -0.96median 1.04 0.22median 1.04 —median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYLNTHCV
Revenue $112.15M $1.56B $14.41M
Gross profit $59.04M $936.02M $7.55M
Operating income -$79.38M $302.34M -$27.71M
Net income -$74.85M $275.31M -$27.42M
Free cash flow -$28.04M $387.83M –
R&D $38.10M $173.09M $20.51M
EPS (diluted) $-0.29 $4.08 $-0.55
Cash & equivalents $124.66M $593.30M –
Total debt – $571.05M –
Shares (diluted) 262.10M 67.52M 49.94M
Enterprise value $1.46B $4.69B $348.56M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYLNTHCV
P/E -25.9x 23.7x -12.3x
P/FCF -62.8x 16.9x –
P/Operating cash flow -73.3x 15.8x –
P/S 15.7x 4.2x 23.4x
P/B 9.3x 5.0x 25.7x
P/Tangible book 9.6x 10.5x 25.7x
EV/EBITDA -22.6x 16.5x -12.3x
EV/EBIT -20.6x 21.5x -12.2x
EV/Revenue 14.6x 4.2x 23.4x
EV/FCF -58.4x 16.8x –
EV/Operating cash flow -68.1x 15.8x –
PEG (3Y EPS CAGR) -0.96 0.22 –

Growth

14 metrics
MetricBFLYLNTHCV
Revenue growth (1Y) 28.1% 2.3% 14.6%
Revenue CAGR (3Y) 15.6% 11.4% –
Gross profit growth (1Y) 8.8% -3.4% 11.1%
Gross profit CAGR (3Y) 13.3% 16.3% –
Operating income growth (1Y) -14.8% -30.9% -36.1%
Operating income CAGR (3Y) 21.1% 118.8% –
Net income growth (1Y) -19.1% 1.6% -34.9%
Net income CAGR (3Y) 20.8% 102.1% –
EPS growth (1Y) -12.9% 5.8% 93.8%
EPS CAGR (3Y) 27.0% 105.5% –
Operating cash flow growth (1Y) 19.6% -21.7% –
Operating cash flow CAGR (3Y) 44.5% 14.5% –
Free cash flow growth (1Y) 12.2% -10.1% –
Free cash flow CAGR (3Y) 42.8% 103.0% –

Profitability

14 metrics
MetricBFLYLNTHCV
Gross margin 52.6% 60.1% 52.4%
EBITDA margin -64.4% 25.4% -190.7%
Operating margin -70.8% 19.4% -192.3%
Pretax margin -66.7% 23.3% -190.1%
Net margin -66.7% 17.7% -190.2%
FCF margin -25.0% 24.9% –
Operating cash flow margin -21.4% 26.5% –
Return on equity -39.3% 21.8% -207.5%
Return on assets -26.3% 11.6% -149.3%
Return on invested capital – 12.5% –
Return on capital employed -35.1% 14.8% -209.8%
Asset turnover 0.4x 0.7x 0.8x
Cash conversion (OCF / net income) 0.3x 1.5x –
Stock comp / revenue 21.3% 5.0% –

Financial Health

11 metrics
MetricBFLYLNTHCV
Debt / assets – 23.6% –
Debt / equity – 0.4x –
Net debt / EBITDA – -0.1x –
Debt / FCF – 1.5x –
Liabilities / assets 33.1% 45.7% 29.1%
Equity / assets 66.9% 54.3% 70.9%
Interest coverage -59.4x 15.3x –
Current ratio 4.1x 3.1x 3.4x
Quick ratio 2.7x 2.8x –
Cash ratio 2.1x 1.8x –
Altman Z-score 7.05 5.46 21.31

Shareholder Returns

7 metrics
MetricBFLYLNTHCV
Dividend yield – – –
Net buyback yield -0.4% 2.9% –
Shareholder yield -0.4% 2.9% 0.0%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYLNTHCV
Forward P/E – 17.4xFY2026 –
EPS, next fiscal year $-0.10FY2026 $5.76FY2026 $-0.58FY2026
EPS growth, next FY – -5.3%FY2026 –
EPS growth, the year after – +4.2% –
Revenue, next fiscal year $114.50MFY2026 $1.57BFY2026 $13.91MFY2026
Revenue growth, next FY +17.3%FY2026 +1.8%FY2026 +2.7%FY2026
Revenue growth, the year after +26.0% +12.7% +46.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYLNTHCV
Held by institutions 59.9% 100.0% 10.2%
Institutions holding 245 465 50
Change in shares held, QoQ +13.9% +3.4% +27.6%
Institutions buying 143 248 36
Institutions selling 59 142 8
Buyers to sellers 2.42 1.75 4.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYLNTHCV
BFLY 1.00 0.14 0.07
LNTH 0.14 1.00 0.07
CV 0.07 0.07 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, LNTH and CV?

Lantheus Holdings (LNTH) is the largest by market capitalisation: Butterfly Network (BFLY) $2.02B, Lantheus Holdings (LNTH) $6.52B, CapsoVision (CV) $348.56M.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +28.1%, Lantheus Holdings (LNTH) +2.3%, CapsoVision (CV) +14.6%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Butterfly Network (BFLY) -66.7%, Lantheus Holdings (LNTH) 17.7%, CapsoVision (CV) -190.2%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +236.4%, Lantheus Holdings (LNTH) +72.3%, CapsoVision (CV) +38.9%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Butterfly Network (BFLY) -6.3%/yr, Lantheus Holdings (LNTH) +34.4%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Lantheus Holdings (LNTH) has been the steadiest (Butterfly Network (BFLY) 114.8%, Lantheus Holdings (LNTH) 32.3%, CapsoVision (CV) 96.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, LNTH and CV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lantheus Holdings (LNTH) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.